Market Intelligence chevron_right Pharma & Healthcare chevron_right Vaccine for Influenza
Global Report 2021

Global Vaccine for Influenza Sales Market Report 2024

calendar_todayPublished: Nov 2021 descriptionPages: 138 categoryCategory: Pharma & Healthcare
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Vaccine for Influenza Market Overview
    1.1 Vaccine for Influenza Product Scope
    1.2 Vaccine for Influenza Segment by Type
        1.2.1 Global Vaccine for Influenza Sales by Type (2016 & 2021 & 2027)
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Vaccine for Influenza Segment by Application
        1.3.1 Global Vaccine for Influenza Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Vaccine for Influenza Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Vaccine for Influenza Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Vaccine for Influenza Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Vaccine for Influenza Price Trends (2016-2027)

2 Vaccine for Influenza Estimates and Forecasts by Region
    2.1 Global Vaccine for Influenza Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Vaccine for Influenza Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Vaccine for Influenza Sales Market Share by Region (2016-2021)
        2.2.2 Global Vaccine for Influenza Revenue Market Share by Region (2016-2021)
    2.3 Global Vaccine for Influenza Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Vaccine for Influenza Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Vaccine for Influenza Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Vaccine for Influenza Estimates and Projections (2016-2027)
        2.4.2 Europe Vaccine for Influenza Estimates and Projections (2016-2027)
        2.4.3 China Vaccine for Influenza Estimates and Projections (2016-2027)
        2.4.4 Japan Vaccine for Influenza Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Vaccine for Influenza Estimates and Projections (2016-2027)
        2.4.6 India Vaccine for Influenza Estimates and Projections (2016-2027)
3 Global Vaccine for Influenza Competition Landscape by Players
    3.1 Global Top Vaccine for Influenza Players by Sales (2016-2021)
    3.2 Global Top Vaccine for Influenza Players by Revenue (2016-2021)
    3.3 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2020)
    3.4 Global Vaccine for Influenza Average Price by Company (2016-2021)
    3.5 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Vaccine for Influenza Market Size by Type
    4.1 Global Vaccine for Influenza Historic Market Review by Type (2016-2021)
        4.1.1 Global Vaccine for Influenza Sales Market Share by Type (2016-2021)
        4.1.2 Global Vaccine for Influenza Revenue Market Share by Type (2016-2021)
        4.1.3 Global Vaccine for Influenza Price by Type (2016-2021)
    4.2 Global Vaccine for Influenza Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Vaccine for Influenza Sales Forecast by Type (2022-2027)
        4.2.2 Global Vaccine for Influenza Revenue Forecast by Type (2022-2027)
        4.2.3 Global Vaccine for Influenza Price Forecast by Type (2022-2027)
5 Global Vaccine for Influenza Market Size by Application
    5.1 Global Vaccine for Influenza Historic Market Review by Application (2016-2021)
        5.1.1 Global Vaccine for Influenza Sales Market Share by Application (2016-2021)
        5.1.2 Global Vaccine for Influenza Revenue Market Share by Application (2016-2021)
        5.1.3 Global Vaccine for Influenza Price by Application (2016-2021)
    5.2 Global Vaccine for Influenza Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Vaccine for Influenza Sales Forecast by Application (2022-2027)
        5.2.2 Global Vaccine for Influenza Revenue Forecast by Application (2022-2027)
        5.2.3 Global Vaccine for Influenza Price Forecast by Application (2022-2027)

6 North America Vaccine for Influenza Market Facts & Figures
    6.1 North America Vaccine for Influenza Sales by Company
        6.1.1 North America Vaccine for Influenza Sales by Company (2016-2021)
        6.1.2 North America Vaccine for Influenza Revenue by Company (2016-2021)
    6.2 North America Vaccine for Influenza Sales Breakdown by Type
        6.2.1 North America Vaccine for Influenza Sales Breakdown by Type (2016-2021)
        6.2.2 North America Vaccine for Influenza Sales Breakdown by Type (2022-2027)
    6.3 North America Vaccine for Influenza Sales Breakdown by Application
        6.3.1 North America Vaccine for Influenza Sales Breakdown by Application (2016-2021)
        6.3.2 North America Vaccine for Influenza Sales Breakdown by Application (2022-2027)

7 Europe Vaccine for Influenza Market Facts & Figures
    7.1 Europe Vaccine for Influenza Sales by Company
        7.1.1 Europe Vaccine for Influenza Sales by Company (2016-2021)
        7.1.2 Europe Vaccine for Influenza Revenue by Company (2016-2021)
    7.2 Europe Vaccine for Influenza Sales Breakdown by Type
        7.2.1 Europe Vaccine for Influenza Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Vaccine for Influenza Sales Breakdown by Type (2022-2027)
    7.3 Europe Vaccine for Influenza Sales Breakdown by Application
        7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Vaccine for Influenza Market Facts & Figures
    8.1 China Vaccine for Influenza Sales by Company
        8.1.1 China Vaccine for Influenza Sales by Company (2016-2021)
        8.1.2 China Vaccine for Influenza Revenue by Company (2016-2021)
    8.2 China Vaccine for Influenza Sales Breakdown by Type
        8.2.1 China Vaccine for Influenza Sales Breakdown by Type (2016-2021)
        8.2.2 China Vaccine for Influenza Sales Breakdown by Type (2022-2027)
    8.3 China Vaccine for Influenza Sales Breakdown by Application
        8.3.1 China 248 Sales Breakdown by Application (2016-2021)
        8.3.2 China 248 Sales Breakdown by Application (2022-2027)

9 Japan Vaccine for Influenza Market Facts & Figures
    9.1 Japan Vaccine for Influenza Sales by Company
        9.1.1 Japan Vaccine for Influenza Sales by Company (2016-2021)
        9.1.2 Japan Vaccine for Influenza Revenue by Company (2016-2021)
    9.2 Japan Vaccine for Influenza Sales Breakdown by Type
        9.2.1 Japan Vaccine for Influenza Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Vaccine for Influenza Sales Breakdown by Type (2022-2027)
    9.3 Japan Vaccine for Influenza Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Vaccine for Influenza Market Facts & Figures
    10.1 Southeast Asia Vaccine for Influenza Sales by Company
        10.1.1 Southeast Asia Vaccine for Influenza Sales by Company (2016-2021)
        10.1.2 Southeast Asia Vaccine for Influenza Revenue by Company (2016-2021)
    10.2 Southeast Asia Vaccine for Influenza Sales Breakdown by Type
        10.2.1 Southeast Asia Vaccine for Influenza Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Vaccine for Influenza Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Vaccine for Influenza Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Vaccine for Influenza Market Facts & Figures
    11.1 India Vaccine for Influenza Sales by Company
        11.1.1 India Vaccine for Influenza Sales by Company (2016-2021)
        11.1.2 India Vaccine for Influenza Revenue by Company (2016-2021)
    11.2 India Vaccine for Influenza Sales Breakdown by Type
        11.2.1 India Vaccine for Influenza Sales Breakdown by Type (2016-2021)
        11.2.2 India Vaccine for Influenza Sales Breakdown by Type (2022-2027)
    11.3 India Vaccine for Influenza Sales Breakdown by Application
        11.3.1 India Vaccine for Influenza Sales Breakdown by Application (2016-2021)
        11.3.2 India Vaccine for Influenza Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Vaccine for Influenza Business
    12.1 Sanofi
        12.1.1 Sanofi Corporation Information
        12.1.2 Sanofi Business Overview
        12.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Sanofi Vaccine for Influenza Products Offered
        12.1.5 Sanofi Recent Development
    12.2 CSL
        12.2.1 CSL Corporation Information
        12.2.2 CSL Business Overview
        12.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 CSL Vaccine for Influenza Products Offered
        12.2.5 CSL Recent Development
    12.3 GSK
        12.3.1 GSK Corporation Information
        12.3.2 GSK Business Overview
        12.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 GSK Vaccine for Influenza Products Offered
        12.3.5 GSK Recent Development
    12.4 Mylan
        12.4.1 Mylan Corporation Information
        12.4.2 Mylan Business Overview
        12.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Mylan Vaccine for Influenza Products Offered
        12.4.5 Mylan Recent Development
    12.5 Hulan Bio
        12.5.1 Hulan Bio Corporation Information
        12.5.2 Hulan Bio Business Overview
        12.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Hulan Bio Vaccine for Influenza Products Offered
        12.5.5 Hulan Bio Recent Development
    12.6 AstraZeneca
        12.6.1 AstraZeneca Corporation Information
        12.6.2 AstraZeneca Business Overview
        12.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 AstraZeneca Vaccine for Influenza Products Offered
        12.6.5 AstraZeneca Recent Development
    12.7 CCBIO
        12.7.1 CCBIO Corporation Information
        12.7.2 CCBIO Business Overview
        12.7.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 CCBIO Vaccine for Influenza Products Offered
        12.7.5 CCBIO Recent Development
    ...

13 Vaccine for Influenza Manufacturing Cost Analysis
    13.1 Vaccine for Influenza Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Vaccine for Influenza
    13.4 Vaccine for Influenza Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Vaccine for Influenza Distributors List
    14.3 Vaccine for Influenza Customers

15 Market Dynamics
    15.1 Vaccine for Influenza Market Trends
    15.2 Vaccine for Influenza Drivers
    15.3 Vaccine for Influenza Market Challenges
    15.4 Vaccine for Influenza Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Vaccine for Influenza Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Vaccine for Influenza Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Vaccine for Influenza Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Vaccine for Influenza Sales (K Units) by Region (2016-2021)
    Table 5. Global Vaccine for Influenza Sales Market Share by Region (2016-2021)
    Table 6. Global Vaccine for Influenza Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Vaccine for Influenza Revenue Share by Region (2016-2021)
    Table 8. Global Vaccine for Influenza Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Vaccine for Influenza Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Vaccine for Influenza Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Vaccine for Influenza Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Vaccine for Influenza Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Vaccine for Influenza Sales Share by Company (2016-2021)
    Table 14. Global Vaccine for Influenza Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Vaccine for Influenza Revenue Share by Company (2016-2021)
    Table 16. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Influenza as of 2020)
    Table 17. Global Vaccine for Influenza Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Vaccine for Influenza Manufacturing Sites and Area Served
    Table 19. Manufacturers Vaccine for Influenza Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Vaccine for Influenza Sales (K Units) by Type (2016-2021)
    Table 22. Global Vaccine for Influenza Sales Share by Type (2016-2021)
    Table 23. Global Vaccine for Influenza Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Vaccine for Influenza Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Vaccine for Influenza Sales Share by Type (2022-2027)
    Table 26. Global Vaccine for Influenza Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Vaccine for Influenza Revenue Share by Type (2022-2027)
    Table 28. Global Vaccine for Influenza Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Vaccine for Influenza Sales (K Units) by Application (2016-2021) 
    Table 30. Global Vaccine for Influenza Sales Share by Application (2016-2021)
    Table 31. Global Vaccine for Influenza Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Vaccine for Influenza Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Vaccine for Influenza Sales (K Units) by Application (2022-2027)
    Table 34. Global Vaccine for Influenza Sales Share by Application (2022-2027)
    Table 35. Global Vaccine for Influenza Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Vaccine for Influenza Revenue Share by Application (2022-2027)
    Table 37. Global Vaccine for Influenza Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Vaccine for Influenza Sales (K Units) by Company (2016-2021)
    Table 39. North America Vaccine for Influenza Sales Market Share by Company (2016-2021)
    Table 40. North America Vaccine for Influenza Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Vaccine for Influenza Revenue Market Share by Company (2016-2021)
    Table 42. North America Vaccine for Influenza Sales by Type (2016-2021) & (K Units)
    Table 43. North America Vaccine for Influenza Sales Market Share by Type (2016-2021)
    Table 44. North America Vaccine for Influenza Sales by Type (2022-2027) & (K Units)
    Table 45. North America Vaccine for Influenza Sales Market Share by Type (2022-2027)
    Table 46. North America Vaccine for Influenza Sales by Application (2016-2021) & (K Units)
    Table 47. North America Vaccine for Influenza Sales Market Share by Application (2016-2021)
    Table 48. North America Vaccine for Influenza Sales by Application (2022-2027) & (K Units)
    Table 49. North America Vaccine for Influenza Sales Market Share by Application (2022-2027)
    Table 50. Europe Vaccine for Influenza Sales (K Units) by Company (2016-2021)
    Table 51. Europe Vaccine for Influenza Sales Market Share by Company (2016-2021)
    Table 52. Europe Vaccine for Influenza Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Vaccine for Influenza Revenue Market Share by Company (2016-2021)
    Table 54. Europe Vaccine for Influenza Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Vaccine for Influenza Sales Market Share by Type (2016-2021)
    Table 56. Europe Vaccine for Influenza Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Vaccine for Influenza Sales Market Share by Type (2022-2027)
    Table 58. Europe Vaccine for Influenza Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Vaccine for Influenza Sales Market Share by Application (2016-2021)
    Table 60. Europe Vaccine for Influenza Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Vaccine for Influenza Sales Market Share by Application (2022-2027)
    Table 62. China Vaccine for Influenza Sales (K Units) by Company (2016-2021)
    Table 63. China Vaccine for Influenza Sales Market Share by Company (2016-2021)
    Table 64. China Vaccine for Influenza Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Vaccine for Influenza Revenue Market Share by Company (2016-2021)
    Table 66. China Vaccine for Influenza Sales by Type (2016-2021) & (K Units)
    Table 67. China Vaccine for Influenza Sales Market Share by Type (2016-2021)
    Table 68. China Vaccine for Influenza Sales by Type (2022-2027) & (K Units)
    Table 69. China Vaccine for Influenza Sales Market Share by Type (2022-2027)
    Table 70. China Vaccine for Influenza Sales by Application (2016-2021) & (K Units)
    Table 71. China Vaccine for Influenza Sales Market Share by Application (2016-2021)
    Table 72. China Vaccine for Influenza Sales by Application (2022-2027) & (K Units)
    Table 73. China Vaccine for Influenza Sales Market Share by Application (2022-2027)
    Table 74. Japan Vaccine for Influenza Sales (K Units) by Company (2016-2021)
    Table 75. Japan Vaccine for Influenza Sales Market Share by Company (2016-2021)
    Table 76. Japan Vaccine for Influenza Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Vaccine for Influenza Revenue Market Share by Company (2016-2021)
    Table 78. Japan Vaccine for Influenza Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Vaccine for Influenza Sales Market Share by Type (2016-2021)
    Table 80. Japan Vaccine for Influenza Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Vaccine for Influenza Sales Market Share by Type (2022-2027)
    Table 82. Japan Vaccine for Influenza Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Vaccine for Influenza Sales Market Share by Application (2016-2021)
    Table 84. Japan Vaccine for Influenza Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Vaccine for Influenza Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Vaccine for Influenza Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Vaccine for Influenza Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Vaccine for Influenza Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Vaccine for Influenza Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Vaccine for Influenza Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Vaccine for Influenza Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Vaccine for Influenza Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Vaccine for Influenza Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Vaccine for Influenza Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Vaccine for Influenza Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Vaccine for Influenza Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Vaccine for Influenza Sales Market Share by Application (2022-2027)
    Table 98. India Vaccine for Influenza Sales (K Units) by Company (2016-2021)
    Table 99. India Vaccine for Influenza Sales Market Share by Company (2016-2021)
    Table 100. India Vaccine for Influenza Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Vaccine for Influenza Revenue Market Share by Company (2016-2021)
    Table 102. India Vaccine for Influenza Sales by Type (2016-2021) & (K Units)
    Table 103. India Vaccine for Influenza Sales Market Share by Type (2016-2021)
    Table 104. India Vaccine for Influenza Sales by Type (2022-2027) & (K Units)
    Table 105. India Vaccine for Influenza Sales Market Share by Type (2022-2027)
    Table 106. India Vaccine for Influenza Sales by Application (2016-2021) & (K Units)
    Table 107. India Vaccine for Influenza Sales Market Share by Application (2016-2021)
    Table 108. India Vaccine for Influenza Sales by Application (2022-2027) & (K Units)
    Table 109. India Vaccine for Influenza Sales Market Share by Application (2022-2027)
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Sanofi Vaccine for Influenza Product
    Table 114. Sanofi Recent Development
    Table 115. CSL Corporation Information
    Table 116. CSL Description and Business Overview
    Table 117. CSL Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. CSL Vaccine for Influenza Product
    Table 119. CSL Recent Development
    Table 120. GSK Corporation Information
    Table 121. GSK Description and Business Overview
    Table 122. GSK Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. GSK Vaccine for Influenza Product
    Table 124. GSK Recent Development
    Table 125. Mylan Corporation Information
    Table 126. Mylan Description and Business Overview
    Table 127. Mylan Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Mylan Vaccine for Influenza Product
    Table 129. Mylan Recent Development
    Table 130. Hulan Bio Corporation Information
    Table 131. Hulan Bio Description and Business Overview
    Table 132. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Hulan Bio Vaccine for Influenza Product
    Table 134. Hulan Bio Recent Development
    Table 135. AstraZeneca Corporation Information
    Table 136. AstraZeneca Description and Business Overview
    Table 137. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. AstraZeneca Vaccine for Influenza Product
    Table 139. AstraZeneca Recent Development
    Table 140. CCBIO Corporation Information
    Table 141. CCBIO Description and Business Overview
    Table 142. CCBIO Vaccine for Influenza Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. CCBIO Vaccine for Influenza Product
    Table 144. CCBIO Recent Development
    Table 145. Production Base and Market Concentration Rate of Raw Material
    Table 146. Key Suppliers of Raw Materials
    Table 147. Vaccine for Influenza Distributors List
    Table 148. Vaccine for Influenza Customers List
    Table 149. Vaccine for Influenza Market Trends
    Table 150. Vaccine for Influenza Market Drivers
    Table 151. Vaccine for Influenza Market Challenges
    Table 152. Vaccine for Influenza Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine for Influenza Product Picture
    Figure 2. Global Vaccine for Influenza Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Vaccine for Influenza Sales Market Share by Application in 2021 & 2027
    Figure 6. For Children (6 months to 3 years) Examples
    Figure 7. For Adults and Children over 3 years Examples
    Figure 8. Global Vaccine for Influenza Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Vaccine for Influenza Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global Vaccine for Influenza Sales (K Units) Growth Rate (2016-2027)
    Figure 11. Global Vaccine for Influenza Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 12. Global Vaccine for Influenza Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global Vaccine for Influenza Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America Vaccine for Influenza Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America Vaccine for Influenza Sales (K Units) Growth Rate (2016-2027)
    Figure 16. Europe Vaccine for Influenza Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe Vaccine for Influenza Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China Vaccine for Influenza Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China Vaccine for Influenza Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan Vaccine for Influenza Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan Vaccine for Influenza Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia Vaccine for Influenza Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Vaccine for Influenza Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India Vaccine for Influenza Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India Vaccine for Influenza Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest Vaccine for Influenza Players Market Share by Revenue in Vaccine for Influenza: 2016 & 2020
    Figure 27. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Vaccine for Influenza Revenue Share by Type (2016-2021)
    Figure 29. Global Vaccine for Influenza Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global Vaccine for Influenza Revenue Share by Application (2016-2021)
    Figure 31. Global Vaccine for Influenza Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America Vaccine for Influenza Sales Market Share by Type in 2020
    Figure 33. North America Vaccine for Influenza Sales Market Share by Application in 2020
    Figure 34. Europe Vaccine for Influenza Sales Market Share by Type in 2020
    Figure 35. Europe Vaccine for Influenza Sales Market Share by Application in 2020
    Figure 36. China Vaccine for Influenza Sales Market Share by Type in 2020
    Figure 37. China Vaccine for Influenza Sales Market Share by Application in 2020
    Figure 38. Japan Vaccine for Influenza Sales Market Share by Type in 2020
    Figure 39. Japan Vaccine for Influenza Sales Market Share by Application in 2020
    Figure 40. Southeast Asia Vaccine for Influenza Sales Market Share by Type in 2020
    Figure 41. Southeast Asia Vaccine for Influenza Sales Market Share by Application in 2020
    Figure 42. India Vaccine for Influenza Sales Market Share by Type in 2020
    Figure 43. India Vaccine for Influenza Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of Vaccine for Influenza 
    Figure 46. Manufacturing Process Analysis of Vaccine for Influenza
    Figure 47. Vaccine for Influenza Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation 
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO

Frequently Asked Questions

What is the USP of the report? expand_more
Vaccine for Influenza report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Vaccine for Influenza report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Vaccine for Influenza report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.